SDIC
CHRS icon

South Dakota Investment Council’s Coherus Oncology CHRS Stock Holding History

South Dakota Investment Council’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-9,648
Closed -$125K – 617
2022
Q1 		$125K Sell
9,648
-96,473
-91% -$1.23M ﹤0.01% 563
2021
Q4 		$1.69M Hold
106,121
– – 0.03% 391
2021
Q3 		$1.71M Sell
106,121
-59,300
-36% -$869K 0.03% 374
2021
Q2 		$2.29M Buy
165,421
+112,890
+215% +$1.6M 0.04% 322
2021
Q1 		$767K Buy
52,531
+34,158
+186% +$580K 0.01% 506
2020
Q4 		$319K Hold
18,373
– – 0.01% 553
2020
Q3 		$337K Buy
18,373
+7,373
+67% +$137K 0.01% 527
2020
Q2 		$196K Buy
+11,000
New +$186K ﹤0.01% 552

Other funds holding CHRS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

South Dakota Investment Council's CHRS Position: Q2 2022 in Review

South Dakota Investment Council sold out of Coherus Oncology (CHRS) in Q2 2022, closing a stake of 9,648 shares — an estimated $125K sold.

South Dakota Investment Council first reported a position in CHRS in Q2 2020 and held it in 8 quarters. The position peaked at $2.29M in Q2 2021. 176 funds tracked by Wall St. Rank hold CHRS as of Q2 2022.

  • South Dakota Investment Council reported no remaining Coherus Oncology position as of Q2 2022 after selling out during the quarter.
  • South Dakota Investment Council sold 9,648 Coherus Oncology shares in Q2 2022, an estimated $125K.
  • South Dakota Investment Council first reported a position in Coherus Oncology in Q2 2020 and held it in 8 quarters.
  • South Dakota Investment Council's Coherus Oncology position peaked at $2.29M in Q2 2021.
  • 176 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2022.

Based on South Dakota Investment Council's 13F filing for Q2 2022, filed 11 Aug 2022.